Harris WH - Search Results

1

Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.

Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, Mccallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ. Cleton-Jansen AM, et al. Among authors: harris wh. Cancer Res. 2001 Feb 1;61(3):1171-7. Cancer Res. 2001. PMID: 11221848

2

Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, Sheer D. Roylance R, et al. Cancer Res. 1999 Apr 1;59(7):1433-6. Cancer Res. 1999. PMID: 10197608

3

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD. Barnes DM, et al. Among authors: harris wh. Br J Cancer. 1996 Nov;74(9):1445-51. doi: 10.1038/bjc.1996.563. Br J Cancer. 1996. PMID: 8912543 Free PMC article.

4

Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.

Miles DW, Harris WH, Gillett CE, Smith P, Barnes DM. Miles DW, et al. Among authors: harris wh. Int J Cancer. 1999 Aug 20;84(4):354-9. doi: 10.1002/(sici)1097-0215(19990820)84:4<354::aid-ijc4>3.0.co;2-6. Int J Cancer. 1999. PMID: 10404085 Clinical Trial.

5

Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast.

Leong AC, Hanby AM, Potts HW, Tan DS, Skilton D, Ryder K, Harris WH, Liebmann RD, Barnes DM, Gillett CE. Leong AC, et al. Among authors: harris wh. Int J Cancer. 2000 Jan 20;89(1):26-31. doi: 10.1002/(sici)1097-0215(20000120)89:1<26::aid-ijc5>3.0.co;2-8. Int J Cancer. 2000. PMID: 10719727

6

Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer.

Steiner P, Barnes DM, Harris WH, Weinberg RA. Steiner P, et al. Among authors: harris wh. Nat Genet. 1997 Aug;16(4):332-3. doi: 10.1038/ng0897-332. Nat Genet. 1997. PMID: 9241265 No abstract available.

7

Imaging protein kinase Calpha activation in cells.

Ng T, Squire A, Hansra G, Bornancin F, Prevostel C, Hanby A, Harris W, Barnes D, Schmidt S, Mellor H, Bastiaens PI, Parker PJ. Ng T, et al. Science. 1999 Mar 26;283(5410):2085-9. doi: 10.1126/science.283.5410.2085. Science. 1999. PMID: 10092232

8

Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified?

Miller WR, Scott WN, Harris WH, Wang D. Miller WR, et al. Among authors: harris wh. Cancer Detect Prev. 1992;16(2):99-106. Cancer Detect Prev. 1992. PMID: 1600527

9

Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.

Daly RJ, Harris WH, Wang DY, Darbre PD. Daly RJ, et al. Among authors: harris wh. Cell Growth Differ. 1991 Sep;2(9):457-64. Cell Growth Differ. 1991. PMID: 1661135

10

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.

Catteau A, Harris WH, Xu CF, Solomon E. Catteau A, et al. Among authors: harris wh. Oncogene. 1999 Mar 18;18(11):1957-65. doi: 10.1038/sj.onc.1202509. Oncogene. 1999. PMID: 10208417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters